RESUMEN
We present a 32-year-old patient who, from age 7 months, developed photophobia, left-eye ptosis and progressive muscular weakness. At age 7 years, she showed normal psychomotor development, bilateral ptosis and exercise-induced weakness with severe acidosis. Basal blood and urine lactate were normal, increasing dramatically after effort. PDHc deficiency was demonstrated in muscle and fibroblasts without detectable PDHA1 mutations. Ketogenic diet was ineffective, however thiamine gave good response although bilateral ptosis and weakness with acidosis on exercise persisted. Recently, DLD gene analysis revealed a homozygous missense mutation, c.1440 A>G (p.I480M), in the interface domain. Both parents are heterozygous and DLD activity in the patient's fibroblasts is undetectable. The five patients that have been reported with DLD-interface mutations suffered fatal deteriorations. Our patient's disease is milder, only myopathic, more similar to that due to mutation p.G229C in the NAD(+)-binding domain. Two of the five patients presented mutations (p.D479V and p.R482G) very close to the present case (p.I480M). Despite differing degrees of clinical severity, all three had minimal clues to DLD deficiency, with occasional minor increases in α-ketoglutarate and branched-chain amino acids. In the two other patients, hypertrophic cardiomyopathy was a significant feature that has been attributed to moonlighting proteolytic activity of monomeric DLD, which can degrade other mitochondrial proteins, such as frataxin. Our patient does not have cardiomyopathy, suggesting that p.I480M may not affect the DLD ability to dimerize to the same extent as p.D479V and p.R482G. Our patient, with a novel mutation in the DLD interface and mild clinical symptoms, further broadens the spectrum of this enzyme defect.
Asunto(s)
Acidosis Láctica/genética , Enfermedad de la Orina de Jarabe de Arce/genética , Debilidad Muscular/genética , Mutación Missense , Ácido Tióctico/análogos & derivados , Acidosis Láctica/diagnóstico , Acidosis Láctica/tratamiento farmacológico , Acidosis Láctica/enzimología , Acidosis Láctica/fisiopatología , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Biomarcadores/sangre , Biomarcadores/orina , Blefaroptosis/diagnóstico , Blefaroptosis/enzimología , Blefaroptosis/genética , Células Cultivadas , Análisis Mutacional de ADN , Suplementos Dietéticos , Femenino , Predisposición Genética a la Enfermedad , Herencia , Heterocigoto , Homocigoto , Humanos , Ácido Láctico/sangre , Ácido Láctico/orina , Enfermedad de la Orina de Jarabe de Arce/diagnóstico , Enfermedad de la Orina de Jarabe de Arce/tratamiento farmacológico , Enfermedad de la Orina de Jarabe de Arce/enzimología , Enfermedad de la Orina de Jarabe de Arce/fisiopatología , Datos de Secuencia Molecular , Fuerza Muscular/genética , Debilidad Muscular/diagnóstico , Debilidad Muscular/tratamiento farmacológico , Debilidad Muscular/enzimología , Debilidad Muscular/fisiopatología , Linaje , Fenotipo , Fotofobia/diagnóstico , Fotofobia/enzimología , Fotofobia/genética , Estructura Terciaria de Proteína , Enfermedad por Deficiencia del Complejo Piruvato Deshidrogenasa/diagnóstico , Enfermedad por Deficiencia del Complejo Piruvato Deshidrogenasa/enzimología , Enfermedad por Deficiencia del Complejo Piruvato Deshidrogenasa/genética , España , Tiamina/uso terapéutico , Ácido Tióctico/química , Ácido Tióctico/deficiencia , Ácido Tióctico/genética , Resultado del TratamientoRESUMEN
This report presents a case of mitochondrial respiratory chain deficiency in a neonate with elevated plasma lactate, hypotonia, developmental delay, and dysmorphic features. The initial biochemical analyses of muscle tissue for mitochondrial function were normal. Additional testing on skin fibroblasts performed owing to a high clinical suspicion of a possible mitochondrial disorder indicated a deficiency of mitochondrial complex I. Western blotting of samples obtained both from muscle and fibroblast tissues also revealed an extensive defect in mitochondrial respiratory chain complex I, confirming the diagnosis. These observations underscore the fact that both enzymatic and immunological assays should be undertaken in alternate tissues when muscle biopsies are inconclusive in highly suspected cases.
Asunto(s)
Complejo I de Transporte de Electrón/deficiencia , Enfermedades Mitocondriales/diagnóstico , Músculo Esquelético/enzimología , Acidosis Láctica/diagnóstico , Acidosis Láctica/enzimología , Acidosis Láctica/genética , Acidosis Láctica/patología , Atrofia , Biopsia , Western Blotting , Carnitina/análogos & derivados , Carnitina/sangre , Quistes del Sistema Nervioso Central/diagnóstico , Quistes del Sistema Nervioso Central/enzimología , Quistes del Sistema Nervioso Central/genética , Quistes del Sistema Nervioso Central/patología , Ventrículos Cerebrales/patología , Análisis Mutacional de ADN , Diagnóstico Diferencial , Complejo I de Transporte de Electrón/genética , Femenino , Fibroblastos/enzimología , Fibroblastos/patología , Lóbulo Frontal/patología , Humanos , Recién Nacido , Imagen por Resonancia Magnética , Enfermedades Mitocondriales/enzimología , Enfermedades Mitocondriales/genética , Enfermedades Mitocondriales/patología , Músculo Esquelético/patología , Fibras Nerviosas Mielínicas/patología , Mutación PuntualRESUMEN
Pyruvate dehydrogenase deficiency is an important cause of primary lactic acidosis. Most cases occur as a result of mutations in the gene for the E1 alpha subunit of the complex, with a small number resulting from mutations in genes for other components, most commonly the E3 and E3-binding protein subunits. We describe pyruvate dehydrogenase E3-binding protein deficiency in two siblings in each of two unrelated families from Kuwait. The index patient in each family had reduced pyruvate dehydrogenase activity in cultured fibroblasts and no detectable immunoreactive E3-binding protein. Both were homozygous for nonsense mutations in the E3-binding protein gene, one involving the codon for glutamine 266, the other the codon for tryptophan 5.
Asunto(s)
Acidosis Láctica/enzimología , Péptidos/deficiencia , Secuencia de Bases , Células Cultivadas , Codón/genética , Codón sin Sentido , Consanguinidad , ADN Complementario/química , Femenino , Fibroblastos/enzimología , Glutamina/genética , Homocigoto , Humanos , Lactante , Recién Nacido , Kuwait , Imagen por Resonancia Magnética , Péptidos/genética , Complejo Piruvato Deshidrogenasa/genética , Siria/etnología , Triptófano/genéticaRESUMEN
We describe an infant girl who presented at age 4 1/2 months with developmental delay, infantile spasms, hypotonia, and elevated lactate levels in the blood and cerebrospinal fluid. She had minor dysmorphic features. Muscle phosphorus magnetic resonance spectroscopy demonstrated reduced phosphocreatine and increased inorganic phosphate, suggesting a defect in oxidative energy metabolism. Pyruvate dehydrogenase activity in cultured fibroblasts was reduced (0.35 nmol/mg mitochondrial protein/min; controls 0.7-1.1 nmol/mg mitochondrial protein/min). Immunoblotting demonstrated a reduced amount of pyruvate dehydrogenase (PDH) E1 alpha immunoreactive protein with normal amounts of E2 protein. Single-strand conformational polymorphism analysis of E1 alpha cDNA prepared from fibroblasts disclosed an abnormal migration pattern, suggesting heterozygosity for a mutant allele. Dideoxy-fingerprinting of PCR-amplified genomic DNA was used to localize the mutation to exon 10. Direct sequencing demonstrated a novel 13-bp insertion mutation that would lead to premature termination of the protein product. This study further extends the allelic heterogeneity underlying PDH deficiency. The demonstration of bioenergetic abnormalities in muscle emphasizes that hypotonia in PDH deficiency may have combined peripheral and central etiologies. The results further suggest that the association of cerebral dysgenesis with lactic acidemia in females may be a useful clue to PDH deficiency.